| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| AUPHAurinia Pharmaceuticals Inc. | 2.01B | 15.23 | 387.53 | 33.97% | 29.28% | 21.28% | 2.2% | 0.21 |
| ARGXargenx SE | 49.47B | 799.33 | 62.55 | 78.6% | 23.34% | 15.14% | 0.01 | |
| INVAInnoviva, Inc. | 1.48B | 19.74 | 54.83 | 15.54% | 32.78% | 12.61% | 12.77% | 0.65 |
| GLPGGalapagos N.V. | 2.25B | 34.12 | 30.46 | 14.99% | -151.94% | -15.16% | 0.00 | |
| PTGXProtagonist Therapeutics, Inc. | 5.33B | 85.23 | 20.15 | 6.24% | 21.94% | 7.11% | 3.43% | 0.02 |
| ALMSAlumis Inc. Common Stock | 2.86B | 24.34 | -2.34 | -11.08% | -63.71% | 0.12 | ||
| ZBIOZenas BioPharma, Inc. | 1.21B | 22.56 | -6 | -90% | -12.66% | -96.68% | 0.00 | |
| ORKAOruka Therapeutics, Inc. | 1.55B | 32.00 | -6.41 | -22.44% | 0.00 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 7.49M | 15.47M | 43.69M | 24.57M | 78.46M | 41.24M | 497.28M | 410.75M | 1.23B | 2.19B |
| Revenue Growth % | 0.64% | 1.07% | 1.82% | -0.44% | 2.19% | -0.47% | 11.06% | -0.17% | 1.99% | 0.79% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29.43M | 117.83M | 227.29M |
| COGS % of Revenue | - | - | - | - | - | - | - | 0.07% | 0.1% | 0.1% |
| Gross Profit | 7.49M | 15.47M | 43.69M | 24.57M | 78.46M | 41.24M | 497.28M | 381.31M | 1.11B | 1.96B |
| Gross Margin % | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 0.93% | 0.9% | 0.9% |
| Gross Profit Growth % | 0.64% | 1.07% | 1.82% | -0.44% | 2.19% | -0.47% | 11.06% | -0.23% | 1.91% | 0.77% |
| Operating Expenses | 24.55M | 38M | 71.2M | 118.2M | 277.35M | 518.86M | 846.02M | 1.1B | 1.53B | 1.98B |
| OpEx % of Revenue | 3.28% | 2.46% | 1.63% | 4.81% | 3.53% | 12.58% | 1.7% | 2.68% | 1.25% | 0.91% |
| Selling, General & Admin | 5.38M | 7.37M | 14.93M | 31.42M | 72.15M | 170.55M | 305.52M | 469.92M | 709.54M | 1.06B |
| SG&A % of Revenue | 0.72% | 0.48% | 0.34% | 1.28% | 0.92% | 4.14% | 0.61% | 1.14% | 0.58% | 0.48% |
| Research & Development | 22.56M | 33.19M | 62.07M | 95.64M | 220.77M | 370.49M | 580.52M | 663.37M | 859.49M | 983.42M |
| R&D % of Revenue | 3.01% | 2.14% | 1.42% | 3.89% | 2.81% | 8.98% | 1.17% | 1.62% | 0.7% | 0.45% |
| Other Operating Expenses | -3.39M | -2.56M | -5.81M | -8.86M | -15.56M | -22.18M | -40.02M | -31.63M | -35.5M | -54.16M |
| Operating Income | -17.06M | -22.52M | -27.51M | -93.63M | -198.89M | -477.62M | -348.75M | -720.34M | -425.05M | -21.65M |
| Operating Margin % | -2.28% | -1.46% | -0.63% | -3.81% | -2.53% | -11.58% | -0.7% | -1.75% | -0.35% | -0.01% |
| Operating Income Growth % | -0.31% | -0.32% | -0.22% | -2.4% | -1.12% | -1.4% | 0.27% | -1.07% | 0.41% | 0.95% |
| EBITDA | -16.85M | -22.17M | -26.99M | -93.06M | -196.47M | -473.7M | -342.88M | -616M | -313.57M | -4.13M |
| EBITDA Margin % | -2.25% | -1.43% | -0.62% | -3.79% | -2.5% | -11.49% | -0.69% | -1.5% | -0.26% | -0% |
| EBITDA Growth % | -0.31% | -0.32% | -0.22% | -2.45% | -1.11% | -1.41% | 0.28% | -0.8% | 0.49% | 0.99% |
| D&A (Non-Cash Add-back) | 214.29K | 351.27K | 521.87K | 563.94K | 2.42M | 3.92M | 5.87M | 104.34M | 111.48M | 17.53M |
| EBIT | -16.74M | -22.52M | -32.97M | -93.63M | -175.78M | -604.95M | -398.65M | -727.12M | -303.59M | 87.64M |
| Net Interest Income | 83.09K | 64.15K | 197.95K | 4.23M | 8.67M | 4.75M | 2.39M | 22.55M | 92.06M | 136.28M |
| Interest Income | 83.09K | 64.15K | 197.95K | 4.23M | 8.8M | 5.15M | 3.48M | 24.74M | 92.96M | 138.5M |
| Interest Expense | 0 | 0 | 0 | 0 | 139K | 403.66K | 1.1M | 2.19M | 904K | 2.22M |
| Other Income/Expense | 320.34K | 44.17K | -5.46M | 18.3M | 22.97M | -127.73M | -51M | -8.97M | 120.55M | 106.83M |
| Pretax Income | -16.74M | -22.48M | -32.97M | -75.32M | -175.92M | -605.35M | -399.74M | -729.31M | -304.5M | 85.18M |
| Pretax Margin % | -2.23% | -1.45% | -0.75% | -3.07% | -2.24% | -14.68% | -0.8% | -1.78% | -0.25% | 0.04% |
| Income Tax | 0 | 0 | 716.22K | 908.26K | 5.29M | 3.1M | 8.52M | -19.72M | -9.44M | -747.86M |
| Effective Tax Rate % | 1% | 1% | 1.02% | 1.01% | 1.03% | 1.01% | 1.02% | 0.97% | 0.97% | 9.78% |
| Net Income | -16.74M | -22.48M | -33.68M | -76.23M | -181.21M | -608.46M | -407.63M | -709.59M | -295.05M | 833.04M |
| Net Margin % | -2.23% | -1.45% | -0.77% | -3.1% | -2.31% | -14.75% | -0.82% | -1.73% | -0.24% | 0.38% |
| Net Income Growth % | -0.33% | -0.34% | -0.5% | -1.26% | -1.38% | -2.36% | 0.33% | -0.74% | 0.58% | 3.82% |
| Net Income (Continuing) | -16.74M | -22.48M | -33.68M | -76.23M | -181.21M | -608.46M | -408.26M | -709.59M | -295.05M | 833.04M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.06 | -1.20 | -1.37 | -2.12 | -4.69 | -13.40 | -7.99 | -13.05 | -5.16 | 12.78 |
| EPS Growth % | -0.33% | -0.13% | -0.14% | -0.55% | -1.21% | -1.86% | 0.4% | -0.63% | 0.6% | 3.48% |
| EPS (Basic) | -1.06 | -1.19 | -1.37 | -2.12 | -4.69 | -13.40 | -7.99 | -13.05 | -5.16 | 13.92 |
| Diluted Shares Outstanding | 15.73M | 18.82M | 24.61M | 35.98M | 38.62M | 45.41M | 51.08M | 54.38M | 57.17M | 65.18M |
| Basic Shares Outstanding | 15.73M | 18.82M | 24.61M | 35.98M | 38.62M | 45.41M | 51.08M | 54.38M | 57.17M | 59.86M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 48.26M | 107.06M | 440.06M | 654.82M | 1.54B | 2.06B | 2.54B | 2.77B | 4.12B | 4.88B |
| Cash & Short-Term Investments | 46.28M | 101.73M | 431.62M | 645.81M | 1.5B | 2B | 2.34B | 2.19B | 3.18B | 3.38B |
| Cash Only | 38.83M | 94.55M | 228.98M | 321.48M | 372.16M | 1.22B | 1.33B | 800.74M | 2.05B | 1.5B |
| Short-Term Investments | 7.45M | 7.18M | 202.64M | 324.33M | 1.13B | 779.65M | 1B | 1.39B | 1.13B | 1.88B |
| Accounts Receivable | 719K | 1.12M | 845K | 214K | 22.61M | 7.44M | 38.22M | 277.27M | 499.27M | 909.1M |
| Days Sales Outstanding | 35.02 | 26.37 | 7.06 | 3.18 | 105.2 | 65.85 | 28.05 | 246.39 | 148.6 | 151.5 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 25.2M | 109.08M | 228.35M | 310.55M | 407.23M |
| Days Inventory Outstanding | - | - | - | - | - | - | - | 2.83K | 961.94 | 653.97 |
| Other Current Assets | 637K | 826.64K | 3.85M | 4.67M | 9.26M | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 2M | 4.18M | 4.92M | 6.88M | 67.54M | 222.41M | 307.3M | 360.06M | 418.72M | 1.32B |
| Property, Plant & Equipment | 272.23K | 805.6K | 811K | 942.58K | 9.18M | 11.58M | 15.84M | 16.23M | 22.68M | 43.52M |
| Fixed Asset Turnover | 27.52x | 19.21x | 53.87x | 26.07x | 8.55x | 3.56x | 31.39x | 25.30x | 54.08x | 50.33x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 7.65K | 17.88K | 15.6K | 64.06K | 45.12M | 167.34M | 171.68M | 174.9M | 125.23M | 181.44M |
| Long-Term Investments | 1.09K | 1.05K | 1.2K | 1.14K | 2.92M | 6.31M | 53.17M | 40.48M | 47.16M | 49.7M |
| Other Non-Current Assets | 1.71M | 3.36M | 4.1M | 5.87M | 10.33M | 22.14M | 34.42M | 49.23M | 126.45M | 120.46M |
| Total Assets | 50.25M | 111.24M | 444.98M | 661.7M | 1.61B | 2.28B | 2.85B | 3.13B | 4.54B | 6.2B |
| Asset Turnover | 0.15x | 0.14x | 0.10x | 0.04x | 0.05x | 0.02x | 0.17x | 0.13x | 0.27x | 0.35x |
| Asset Growth % | -0.14% | 1.21% | 3% | 0.49% | 1.43% | 0.42% | 0.25% | 0.1% | 0.45% | 0.37% |
| Total Current Liabilities | 8.68M | 34M | 29.41M | 45.82M | 160.2M | 328.49M | 301.24M | 302.28M | 422.99M | 669.92M |
| Accounts Payable | 4.97M | 4.61M | 5.27M | 27.63M | 65.64M | 206.32M | 208.85M | 188.72M | 245.56M | 482.7M |
| Days Payables Outstanding | - | - | - | - | - | - | - | 2.34K | 760.63 | 775.16 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 3.48M | 3.51M | 3.42M | 4.65M | 0 |
| Deferred Revenue (Current) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 4.14M | 2.48M | 9.23M | 2.98M | -16.22M | -2.85M | -2.68M | 80.92M | 51.14M | 0 |
| Current Ratio | 5.56x | 3.15x | 14.96x | 14.29x | 9.63x | 6.26x | 8.44x | 9.18x | 9.75x | 7.29x |
| Quick Ratio | 5.56x | 3.15x | 14.96x | 14.29x | 9.63x | 6.19x | 8.08x | 8.42x | 9.01x | 6.68x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | 737.91 | 349.92 | 30.31 |
| Total Non-Current Liabilities | 0 | 10.59M | 1.75M | 8.01K | 250.11M | 276.86M | 14.81M | 18.29M | 21.96M | 34.32M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 5.1M | 6.18M | 7.96M | 9.01M | 15.35M | 32.52M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 1.49M | 6.44M | 8.41M | 5.16M | 0 |
| Other Non-Current Liabilities | 0 | 10.59M | 1.75M | 8.01K | 72K | 156K | 417K | 870K | 1.45M | 1.8M |
| Total Liabilities | 9.49M | 44.59M | 31.16M | 45.83M | 429.81M | 605.36M | 316.05M | 320.56M | 444.95M | 704.24M |
| Total Debt | 0 | 0 | 0 | 0 | 7.32M | 12.5M | 11.46M | 12.43M | 20M | 39.05M |
| Net Debt | -38.83M | -94.55M | -228.98M | -321.48M | -364.84M | -1.2B | -1.32B | -788.31M | -2.03B | -1.46B |
| Debt / Equity | - | - | - | - | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | -1430.88x | -1183.22x | -318.20x | -328.47x | -470.19x | -9.76x |
| Total Equity | 40.76M | 66.65M | 413.81M | 615.87M | 1.18B | 1.67B | 2.53B | 2.81B | 4.1B | 5.5B |
| Equity Growth % | -0.19% | 0.64% | 5.21% | 0.49% | 0.92% | 0.42% | 0.51% | 0.11% | 0.46% | 0.34% |
| Book Value per Share | 2.59 | 3.54 | 16.81 | 17.12 | 30.57 | 36.87 | 49.62 | 51.74 | 71.67 | 84.36 |
| Total Shareholders' Equity | 40.76M | 66.65M | 413.81M | 615.87M | 1.18B | 1.67B | 2.53B | 2.81B | 4.1B | 5.5B |
| Common Stock | 1.73M | 2.12M | 3.86M | 4.12M | 5.21M | 5.74M | 6.23M | 6.64M | 6.39M | 6.98M |
| Retained Earnings | -55.89M | -76.24M | -100.57M | -194.01M | -383.48M | -991.93M | -1.4B | -2.11B | -2.4B | -1.57B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 5.08M | 7.88M | 14.11M | 35.4M | 53.04M | 321.21M | 465.41M | 71.72M | 72.07M | 66.71M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -15.19M | 11.15M | -43.84M | -61.59M | 151.63M | -398.46M | -606.81M | -862.81M | -420.33M | -82.75M |
| Operating CF Margin % | -2.03% | 0.72% | -1% | -2.51% | 1.93% | -9.66% | -1.22% | -2.1% | -0.34% | -0.04% |
| Operating CF Growth % | -1.39% | 1.73% | -4.93% | -0.4% | 3.46% | -3.63% | -0.52% | -0.42% | 0.51% | 0.8% |
| Net Income | -17.06M | -22.52M | -27.51M | -93.63M | -198.89M | -477.62M | -348.75M | -720.34M | -425.05M | 833.04M |
| Depreciation & Amortization | 214.29K | 351.27K | 521.87K | 563.94K | 2.42M | 3.92M | 4.96M | 104.34M | 111.31M | 17.53M |
| Stock-Based Compensation | 2.48M | 3M | 5.12M | 21.94M | 44.24M | 96.93M | 179.37M | 157.03M | 232.97M | 235.18M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 0 | 1.05K | 40.79K | -667K | -6.17M | 6.68M | -101.44M | -27.91M | -30.67M | -843.89M |
| Working Capital Changes | -829K | 30.32M | -22.02M | 10.2M | 310.03M | -28.38M | -340.95M | -375.93M | -308.89M | -324.6M |
| Change in Receivables | -712K | -646K | -146K | -50.33K | -25.71M | 21.96M | -31.63M | -222.26M | -185.69M | -422.36M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | -23.85M | -83.88M | -119.28M | -83.03M | -95.83M |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 245.9M |
| Cash from Investing | 18.38M | -848K | -194.41M | -123.02M | -833.27M | 344.69M | -347.07M | -461.18M | 308.21M | -717.59M |
| Capital Expenditures | -300K | -883K | -414K | -712K | -1.8M | -1.07M | -3.62M | -837K | -812K | -1.8M |
| CapEx % of Revenue | 0.04% | 0.06% | 0.01% | 0.03% | 0.02% | 0.03% | 0.01% | 0% | 0% | 0% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 18.68M | 35.76K | -194M | -122.31M | -831.47M | 345.76M | -115.21M | -89.84M | 49.75M | 45.15M |
| Cash from Financing | 260.2K | 46.93M | 366.35M | 279.88M | 733.73M | 833M | 1.12B | 843.76M | 1.34B | 279.76M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 0 | -1.43M | -26.8M | -12.64M | -20.4M | 22.37M | 32.12M | 86.97M | 143.8M | -21.32M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -15.5M | 10.24M | -44.27M | -62.37M | 104.89M | -403.6M | -728.25M | -966.63M | -464.14M | -151.05M |
| FCF Margin % | -2.07% | 0.66% | -1.01% | -2.54% | 1.34% | -9.79% | -1.46% | -2.35% | -0.38% | -0.07% |
| FCF Growth % | -1.35% | 1.66% | -5.32% | -0.41% | 2.68% | -4.85% | -0.8% | -0.33% | 0.52% | 0.67% |
| FCF per Share | -0.99 | 0.54 | -1.80 | -1.73 | 2.72 | -8.89 | -14.26 | -17.78 | -8.12 | -2.32 |
| FCF Conversion (FCF/Net Income) | 0.91x | -0.50x | 1.30x | 0.81x | -0.84x | 0.65x | 1.49x | 1.22x | 1.42x | -0.10x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 378.4K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -36.86% | -41.86% | -14.02% | -14.81% | -20.18% | -42.63% | -19.37% | -26.54% | -8.54% | 17.36% |
| Return on Invested Capital (ROIC) | -129.05% | - | -26.3% | -29.31% | -26.88% | -55.74% | -31.12% | -33.39% | -15.57% | -0.53% |
| Gross Margin | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 92.83% | 90.39% | 89.62% |
| Net Margin | -223.42% | -145.27% | -77.1% | -310.22% | -230.95% | -1475.29% | -81.97% | -172.76% | -24.06% | 38.03% |
| Debt / Equity | - | - | - | - | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | 0.01x |
| Interest Coverage | - | - | - | - | -1430.88x | -1183.22x | -318.20x | -328.47x | -470.19x | -9.76x |
| FCF Conversion | 0.91x | -0.50x | 1.30x | 0.81x | -0.84x | 0.65x | 1.49x | 1.22x | 1.42x | -0.10x |
| Revenue Growth | 64.07% | 106.51% | 182.33% | -43.75% | 219.3% | -47.44% | 1105.72% | -17.4% | 198.56% | 78.6% |
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| United States | - | - | - | - | - | 377.66M | 1.05B |
| United States Growth | - | - | - | - | - | - | 177.13% |
| EMEA | - | - | - | - | - | - | 72.85M |
| EMEA Growth | - | - | - | - | - | - | - |
| Japan | - | - | - | - | - | 15.76M | 56.43M |
| Japan Growth | - | - | - | - | - | - | 257.98% |
| China | - | - | - | - | - | - | 14.91M |
| China Growth | - | - | - | - | - | - | - |
| Europe | - | - | - | - | - | 5.68M | - |
| Europe Growth | - | - | - | - | - | - | - |
| UNITED STATES | - | - | - | - | 317.4M | - | - |
| UNITED STATES Growth | - | - | - | - | - | - | - |
| CHINA | - | - | - | - | 178.37M | - | - |
| CHINA Growth | - | - | - | - | - | - | - |
| DENMARK | - | - | - | - | 1.39M | - | - |
| DENMARK Growth | - | - | - | - | - | - | - |
| Others | - | - | - | - | 123K | - | - |
| Others Growth | - | - | - | - | - | - | - |
| U | 1K | - | - | 36.13M | - | - | - |
| U Growth | - | - | - | - | - | - | - |
| D | 6.24M | 1.14M | 436K | 299K | - | - | - |
| D Growth | - | -81.79% | -61.62% | -31.42% | - | - | - |
| C | 2.49M | 912K | 40.59M | - | - | - | - |
| C Growth | - | -63.31% | 4350.99% | - | - | - | - |
| L | 27.06M | 18.96M | 27.26M | - | - | - | - |
| L Growth | - | -29.92% | 43.72% | - | - | - | - |
| N | 628K | 470K | - | - | - | - | - |
| N Growth | - | -25.16% | - | - | - | - | - |
argenx SE (ARGX) has a price-to-earnings (P/E) ratio of 62.5x. This suggests investors expect higher future growth.
argenx SE (ARGX) reported $3.95B in revenue for fiscal year 2024. This represents a 271083% increase from $1.5M in 2011.
argenx SE (ARGX) grew revenue by 78.6% over the past year. This is strong growth.
Yes, argenx SE (ARGX) is profitable, generating $922.8M in net income for fiscal year 2024 (38.0% net margin).
argenx SE (ARGX) has a return on equity (ROE) of 17.4%. This is reasonable for most industries.
argenx SE (ARGX) generated $212.8M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.